Literature DB >> 16297171

Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis.

B Fevang1, T E Mollnes, A M Holm, T Ueland, L Heggelund, J K Damås, P Aukrust, S S Frøland.   

Abstract

The importance of the innate immune system, including mannose-binding lectin and the complement system, in common variable immunodeficiency is unclear. The objective of this study was to evaluate mannose-binding lectin and the complement system in relation to clinical and immunological parameters in patients with common variable immunodeficiency. Circulating levels of mannose-binding lectin, complement components, complement activation products and functional capacity of complement pathways were correlated to clinical features within 71 patients and compared with 30 healthy controls. The main findings were; the patients had signs of increased complement activation significantly associated with signs of autoimmunity and immunological hyperactivity; there were no signs of deficiencies of the classical and alternative complement pathways in the patient group; the prevalence of lectin pathway deficiency was the same in patients and controls, but patients with increased frequency of lower respiratory tract infections or bronchiectasis had lower capacity of the lectin pathway than patients without these features (P = 0.002 and 0.004, respectively); the serum concentration of mannose-binding lectin was inversely correlated to the frequency of lower respiratory tract infections (P = 0.002) and bronchiectasis (P = 0.01). We conclude that patients with common variable immunodeficiency have no increased frequency of complement deficiencies but signs of increased complement activation. Our findings suggest that mannose-binding lectin and the lectin complement pathway may protect against lower respiratory tract infection and bronhiectasis in patients with common variable immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297171      PMCID: PMC1809532          DOI: 10.1111/j.1365-2249.2005.02951.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Comparison of thin section computed tomography with bronchography for identifying bronchiectatic segments in patients with chronic sputum production.

Authors:  N C Munro; J C Cooke; D C Currie; B Strickland; P J Cole
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

Review 2.  Mannose-binding lectin: the pluripotent molecule of the innate immune system.

Authors:  M W Turner
Journal:  Immunol Today       Date:  1996-11

3.  Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features.

Authors:  P Aukrust; S S Frøland; F Müller
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

4.  Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system.

Authors:  M Cedzynski; J Szemraj; A S Swierzko; L Bak-Romaniszyn; M Banasik; K Zeman; D C Kilpatrick
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

5.  Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus.

Authors:  Tommy Øhlenschlaeger; Peter Garred; Hans O Madsen; Søren Jacobsen
Journal:  N Engl J Med       Date:  2004-07-15       Impact factor: 91.245

6.  Homozygous C2 deficiency: association with defective alternative pathway function and immunoglobulin deficiency.

Authors:  O Sanal; L Yel; I Tezcan; F Ersoy; A I Berkel
Journal:  Int Arch Allergy Immunol       Date:  1996-06       Impact factor: 2.749

7.  Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex.

Authors:  T E Mollnes; T Lea; S S Frøland; M Harboe
Journal:  Scand J Immunol       Date:  1985-08       Impact factor: 3.487

8.  Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC).

Authors:  T E Mollnes; H Redl; K Høgåsen; A Bengtsson; P Garred; L Speilberg; T Lea; M Oppermann; O Götze; G Schlag
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

9.  Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein.

Authors:  H O Madsen; P Garred; S Thiel; J A Kurtzhals; L U Lamm; L P Ryder; A Svejgaard
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

10.  A population-based study of morbidity and mortality in mannose-binding lectin deficiency.

Authors:  Morten Dahl; Anne Tybjaerg-Hansen; Peter Schnohr; Børge G Nordestgaard
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

View more
  13 in total

1.  Overall reduction in antibody production could contribute to generate pathogenic autoantibodies and autoimmune manifestations.

Authors:  Ricardo García-Muñoz
Journal:  Clin Rheumatol       Date:  2008-12-18       Impact factor: 2.980

2.  Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo.

Authors:  B Fevang; A Yndestad; W J Sandberg; A M Holm; F Müller; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

3.  Mannose-binding lectin polymorphisms in common variable immunodeficiency.

Authors:  Asghar Aghamohammadi; Farshad Foroughi; Nima Rezaei; Saeid Dianat; Ghasem Solgi; Ali Akbar Amirzargar
Journal:  Clin Exp Med       Date:  2009-05-01       Impact factor: 3.984

4.  Systemic lupus erythematosus as a first presentation of common variable immunodeficiency associated with infrequent mannose-binding lectin gene polymorphisms.

Authors:  Maite Torres-Salido; Josefina Cortés-Hernández; Eva Balada; Miquel Vilardell Tarrés; Josep Ordi-Ros
Journal:  Rheumatol Int       Date:  2009-10-23       Impact factor: 2.631

5.  Mannose-binding lectin gene polymorphic variants predispose to the development of bronchopulmonary complications but have no influence on other clinical and laboratory symptoms or signs of common variable immunodeficiency.

Authors:  J Litzman; T Freiberger; B Grimbacher; B Gathmann; U Salzer; T Pavlík; J Vlcek; V Postránecká; Z Trávnícková; V Thon
Journal:  Clin Exp Immunol       Date:  2008-07-11       Impact factor: 4.330

6.  Are mannose-binding lectin gene 2 (MBL2) polymorphisms and MBL deficiency associated with infections?

Authors:  Vandana Pradhan; Ajit Gorakshakar
Journal:  Indian J Hum Genet       Date:  2011-05

7.  MBL2 genotypes and their associations with MBL levels and NICU morbidity in a cohort of Greek neonates.

Authors:  Matthaios Speletas; Antonios Gounaris; Eirini Sevdali; Maria Kompoti; Katerina Konstantinidi; Rozeta Sokou; Elena Tsitsami; Anastasios E Germenis
Journal:  J Immunol Res       Date:  2015-03-24       Impact factor: 4.818

8.  Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.

Authors:  Peter Garred; Andrea J Tenner; Tom E Mollnes
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

9.  Common Variable Immunodeficiency Non-Infectious Disease Endotypes Redefined Using Unbiased Network Clustering in Large Electronic Datasets.

Authors:  Jocelyn R Farmer; Mei-Sing Ong; Sara Barmettler; Lael M Yonker; Ramsay Fuleihan; Kathleen E Sullivan; Charlotte Cunningham-Rundles; Jolan E Walter
Journal:  Front Immunol       Date:  2018-01-09       Impact factor: 7.561

10.  Low Levels of Immunoglobulins and Mannose-Binding Lectin Are Not Associated With Etiology, Severity, or Outcome in Community-Acquired Pneumonia.

Authors:  William W Siljan; Jan C Holter; Ståle H Nymo; Einar Husebye; Thor Ueland; Lillemor Skattum; Vidar Bosnes; Peter Garred; Stig S Frøland; Tom E Mollnes; Pål Aukrust; Lars Heggelund
Journal:  Open Forum Infect Dis       Date:  2018-01-05       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.